![William Edge](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profilo
William Edge is an Investment Consultant of NVM.
Mr. Edge is a Director of the Merlin Fund and the Merlin Biosciences Fund.
He served as a Director of Alizyme Plc until April 1, 2009.
Precedenti posizioni note di William Edge
Società | Posizione | Fine |
---|---|---|
Alizyme Plc
![]() Alizyme Plc Pharmaceuticals: MajorHealth Technology Alizyme Plc was engaged in the development of pharmaceutical products for the diseases related to obesity treatment. The company was founded in 1995 and was headquartered in Cambridge, the United Kingdom. | Direttore/Membro del Consiglio | 01/04/2009 |
NVM Private Equity LLP
![]() NVM Private Equity LLP Investment ManagersFinance NVM Private Equity LLP(NVM Private Equity) is a independent private equity firm founded in 1984. The firm is headquartered in London, the United Kingdom. | Membro del Comitato di Investimento | 30/06/2008 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
Alizyme Plc
![]() Alizyme Plc Pharmaceuticals: MajorHealth Technology Alizyme Plc was engaged in the development of pharmaceutical products for the diseases related to obesity treatment. The company was founded in 1995 and was headquartered in Cambridge, the United Kingdom. | Health Technology |
NVM Private Equity LLP
![]() NVM Private Equity LLP Investment ManagersFinance NVM Private Equity LLP(NVM Private Equity) is a independent private equity firm founded in 1984. The firm is headquartered in London, the United Kingdom. | Finance |
- Borsa valori
- Insiders
- William Edge